Carla Biotherapeutics is a Biotech company developing first-in-class adoptive cell therapies tailored to treat diseases with high unmet medical need with a first focus on aggressive life-threatening cancer. Carla Biotherapeutics is a company of the Landmark Bioventures nexus spin off of the EFS and Franche-Comté University in Besançon. Carla is founded by a team of seasoned clinicians, cell therapy scientists and biotech professional with access to a world-class and unique cell-therapy platform.